Identification of fecal microbes as potential biomarkers for early diagnosis of fatty liver disease in cattle.

Sun H, Liu T, Song X, Shah SMS, Zhang Q, Shi K

Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLD.

Duseja A, De A, Singh SP, Madan K, Rao PN, Shukla A, Choudhuri G, Saigal S, Shalimar, Arora A, Anand AC, Das A, Kumar A, Eapen CE, Devadas K, Shenoy KT, Panigrahi M, Wadhawan M, Rathi M, Choudhary NS, Saraf N, Nath P, Kar S, Alam S, Shah S, Nijhawan S, Acharya SK, Aggarwal V, Saraswat VA, Chawla YK

Detailed physicochemical characterization of charged and neutral LeciPlexÂŽ: loading efficiency and in vitro activity of Voriconazole and Amphotericin B.

Tank S, Dhaygude H, Katawale S, Holm R, Shah S, Shidhaye S, Shinde U, Nagarsenker M

Cardiovascular-Kidney-Metabolic Syndrome.

Shah S, Rangaswami J

The Rise of Hazard Gentrification.

Stoler J, Painter MA, Sharygin E, Shah SH

Sex Differences in Cardiovascular Diseases and Vascular Function in Chronic Kidney Disease.

Oh E, Nowak K, Shah S

Anesthetic considerations for outpatient interventional radiology procedures for cancer patients.

Simon NB, Serafin J, Shah SH, Barnett KM

Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.

Gillessen S, Murphy L, James ND, Sachdeva A, El-Taji O, Abdel-Aty H, Adler AI, Amos C, Attard G, Varughese M, Gale J, Brown S, Srihari N, Birtle AJ, Brown M, Chan K, Chowdhury S, Cross W, Dearnaley DP, Din O, Dutey-Magni P, Gilbert DC, Gilson C, Gray S, Grist E, Hofmann U, Hudson AM, Jain Y, Jeyasangar G, Jones R, Kayani M, Langley RE, Malik Z, Mason MD, Matheson D, McAlpine C, Macnair A, Millman R, Murphy C, Padden-Modi M, Parikh O, Parker C, Rush H, Russell M, Srinivasan R, Sundar S, Tanguay JS, Turco F, Williams P, Sydes MR, Parmar MKB, Brown LC, Clarke NW, STAMPEDE investigators

Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials.

Panaccione R, Feagan BG, Afzali A, Rubin DT, Reinisch W, Panés J, Danese S, Hisamatsu T, Terry NA, Salese L, Van Rampelbergh R, Sahoo A, Vetter ML, Yee J, Han C, Frustaci ME, Wan KYY, Yang Z, Johanns J, Andrews JM, D'Haens GR, Sands BE, GALAXI 2 & 3 Study Group

Impact of ABCB1 gene polymorphism on clopidogrel plasma concentration and cardiovascular events in post-PCI patients.

Razaq A, Iqbal W, Shah ST, Abdur Rauf M, Aldekhail NM, Van Nieuwerburgh F, Siraj S

SSP-CG scaffolds: a synergistic approach to enhance wound healing and tissue repair.

Manzoor T, Dar LA, Mir YB, Shah SA, Ahmad SF, Godha M, Ahmad SM

Clinical utility of thiopurine metabolite levels in monitoring patients with inflammatory bowel disease: A single-centre retrospective study.

Upadhyay KG, Dave MB, Desai DC, Naik PR, Shah SAV, Paradkar MU, Pol SD, Abraham P, Kulkarni SG, Desai ND, Shetty DN, Ashavaid TF, Dherai AJ

Factors Associated With Early Versus Late Mortality Following Pediatric Burn Injury in a Resource-Limited Setting.

Shah SJ, Gondwe J, An S, Hester TE, Charles A

Primary non-hepatoblastoma liver tumors in children-Defining the profile of a very rare subset of childhood tumors.

Mehta A, Parambil BC, Baheti A, Gollamudi VRM, Prasad M, Patil V, Qureshi S, Ramadwar M, Panjwani P, Gala K, Laskar S, Khanna N, Manjali JJ, Shah S, Chinnaswammy G

Rituximab in pathologically confirmed sarcoidosis affecting the central nervous system: a multi-center retrospective study.

Hutto SK, Balaban D, Rohm Z, Lackey E, Samudralwar RD, El Sammak S, Nakirikanti A, Oyerinde E, Bou G, Herman M, Horta L, Taha M, Rivera Torres N, Morrison A, Shah S, Pawate S, Vargas D, Tyor W